158 related articles for article (PubMed ID: 30343642)
1. Feasibility of a Skin Dose Reduction for Nasopharyngeal Carcinoma Treated With High-Intensity-Modulated Delivery Techniques.
Liao X; Li J; Wang P; Yao X; Zhang Y; Tan T; Orlandini LC
Technol Cancer Res Treat; 2018 Jan; 17():1533033818803582. PubMed ID: 30343642
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric Comparisons of Volumetric Modulated Arc Therapy and Tomotherapy for Early T-Stage Nasopharyngeal Carcinoma.
Li S; Zhou Q; Shen LF; Li H; Li ZZ; Yang Z; Lei MJ; Yang XY; Zhang ZJ; Hu YM; Jin ZF; Liu G; Lv ZP; Huang XQ
Biomed Res Int; 2018; 2018():2653497. PubMed ID: 29967769
[TBL] [Abstract][Full Text] [Related]
3. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.
Huang H; Lu H; Feng G; Jiang H; Chen J; Cheng J; Pang Q; Lu Z; Gu J; Peng L; Deng S; Mo Y; Wu D; Wei Y
Radiat Oncol; 2015 Sep; 10():192. PubMed ID: 26377685
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk.
Buglione M; Spiazzi L; Saiani F; Costa L; Shehi B; Lazzari B; Uccelli C; Pasinetti N; Borghetti P; Triggiani L; Donadoni L; Pedretti S; Magrini SM;
Tumori; 2014; 100(3):272-7. PubMed ID: 25076237
[TBL] [Abstract][Full Text] [Related]
6. Helical tomotherapy of nasopharyngeal carcinoma-any advantages over conventional intensity-modulated radiotherapy?
Wu WC; Mui WL; Fung WK
Med Dosim; 2010; 35(2):122-7. PubMed ID: 19931024
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the dosimetric feasibility of hippocampal sparing intensity-modulated radiotherapy in patients with locally advanced nasopharyngeal carcinoma.
Han G; Liu D; Gan H; Denniston KA; Li S; Tan W; Hu D; Zhen W; Wang Z
PLoS One; 2014; 9(2):e90007. PubMed ID: 24587184
[TBL] [Abstract][Full Text] [Related]
9. Anatomical changes and dosimetric analysis of the neck region based on FBCT for nasopharyngeal carcinoma patients during radiotherapy.
Chen A; Chen X; Jiang X; Wang Y; Chi F; Xie D; Zhou M
J Xray Sci Technol; 2024; 32(3):783-795. PubMed ID: 38457140
[TBL] [Abstract][Full Text] [Related]
10. A dosimetric evaluation on applying RTOG-based and CT/MRI-based delineation methods to brachial plexus in radiotherapy of nasopharyngeal carcinoma treated with helical tomotherapy.
Li CH; Wu VW; Chiu G
Br J Radiol; 2019 Oct; 92(1102):20170881. PubMed ID: 29714086
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric difference amongst 3 techniques: TomoTherapy, sliding-window intensity-modulated radiotherapy (IMRT), and RapidArc radiotherapy in the treatment of late-stage nasopharyngeal carcinoma (NPC).
Lee FK; Yip CW; Cheung FC; Leung AK; Chau RM; Ngan RK
Med Dosim; 2014; 39(1):44-9. PubMed ID: 24321222
[TBL] [Abstract][Full Text] [Related]
12. [Dosimetric comparison of intensity-modulated arc radiotherapy and fixed beam dynamic intensity-modulated radiation therapy in nasopharyngeal carcinoma].
Yang Z; Bin S; Lei M; Liu G; Zhang Z; Lu Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 May; 37(5):474-80. PubMed ID: 22659659
[TBL] [Abstract][Full Text] [Related]
13. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric comparison of intensity-modulated stereotactic radiotherapy with other stereotactic techniques for locally recurrent nasopharyngeal carcinoma.
Kung SW; Wu VW; Kam MK; Leung SF; Yu BK; Ngai DY; Wong SC; Chan AT
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):71-9. PubMed ID: 20385452
[TBL] [Abstract][Full Text] [Related]
15. A split-parotid delineation approach for dose optimization in volumetric modulated arc therapy for nasopharyngeal carcinoma patients with parapharyngeal space invasion and level IIa cervical lymph node involvements.
Xiao W; Lin Z; Zhang W; Li M; Wu VW
Br J Radiol; 2016; 89(1060):20150635. PubMed ID: 26838951
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of hippocampus dose for patients undergoing intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Khodayari B; Michaud AL; Stanic S; Wooten OH; Dublin A; Purdy JA; Chen AM
Br J Radiol; 2014 May; 87(1037):20130474. PubMed ID: 24620838
[TBL] [Abstract][Full Text] [Related]
17. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of deformed image-based dose calculations for adaptive radiotherapy of nasopharyngeal carcinoma.
Poon M; Holborn C; Cheng KF; Fung WWK; Chiu G
Med Dosim; 2017 Winter; 42(4):273-281. PubMed ID: 28781156
[TBL] [Abstract][Full Text] [Related]
19. Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study.
Zhou X; Ou X; Xu T; Wang X; Shen C; Ding J; Hu C
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):261-9. PubMed ID: 25066214
[TBL] [Abstract][Full Text] [Related]
20. Comparison of target coverage and dose to organs at risk between simultaneous integrated-boost whole-field intensity-modulated radiation therapy and junctioned intensity-modulated radiation therapy with a conventional radiotherapy field in treatment of nasopharyngeal carcinoma.
Chung JB; Lee JW; Kim JS; Kim IA; Lee DH; Kim YL; Choi KS; Choe BY; Suh TS
Radiol Phys Technol; 2011 Jul; 4(2):180-4. PubMed ID: 21556851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
